首页> 外文期刊>Diabetes >Membrane-Initiated Estrogen Receptor Signaling Mediates Metabolic Homeostasis via Central Activation of Protein Phosphatase 2A
【24h】

Membrane-Initiated Estrogen Receptor Signaling Mediates Metabolic Homeostasis via Central Activation of Protein Phosphatase 2A

机译:膜启动的雌激素受体信号通过蛋白磷酸酶2A的中央激活介导代谢稳态。

获取原文
获取原文并翻译 | 示例
       

摘要

Women gain weight and their diabetes risk increases as they transition through menopause; these changes can be partly reversed by hormone therapy. However, the underlying molecular mechanisms mediating these effects are unknown. A novel knock-in mouse line with the selective blockade of the membrane-initiated estrogen receptor (ER) pathway was used, and we found that the lack of this pathway precipitated excessive weight gain and glucose intolerance independent of food intake and that this was accompanied by impaired adaptive thermogen-esis and reduced physical activity. Notably, the central activation of protein phosphatase (PP) 2A improved metabolic disorders induced by the lack of membrane-initiated ER signaling. Furthermore, the antiobesity effect of estrogen replacement in a murine menopause model was abolished by central PP2A inactivation. These findings define a critical role for membrane-initiated ER signaling in metabolic homeostasis via the central action of PP2A.
机译:随着年龄的增长,女性体重增加,罹患糖尿病的风险也会增加;这些变化可以通过激素疗法部分逆转。但是,尚不清楚介导这些作用的潜在分子机制。使用了一种新型的敲入小鼠系,其选择性阻滞了膜启动的雌激素受体(ER)途径,我们发现缺乏这种途径会导致过度的体重增加和葡萄糖耐受不良,而与食物摄入无关适应性热生成受损和体育活动减少。值得注意的是,蛋白磷酸酶(PP)2A的中枢激活可改善由缺乏膜引发的ER信号传导引起的代谢紊乱。此外,雌性激素替代在小鼠更年期模型中的抗肥胖作用被中枢PP2A灭活所消除。这些发现通过PP2A的中枢作用确定了膜启动的ER信号在代谢稳态中的关键作用。

著录项

  • 来源
    《Diabetes》 |2018年第8期|1524-1537|共14页
  • 作者单位

    Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA,Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

    Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

    Obesity and Metabolism Laboratory, U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA;

    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

    Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号